QIAGEN Pharmacogenomic Insights (PGXI) is a new knowledgebase designed to help scientific and translational researchers better understand how an individual's genetic make-up influences their response to medications.

Built upon a legacy platform used to deliver more than 1.6 million PGx annotations for more than 250 clinical research laboratories, PGXI provides a streamlined and automated approach that enables labs to efficiently and confidently produce evidence-backed insights for pharmacogenomic markers.

Why is PGXI a game-changer for PGx programs?

• Expert-curated content - Contains expert-curated data from all established PGx information sources, including the FDA, CPIC, DPWG, PharmVar, and PubMed, to provide accurate, up-to-date evidence in one centralized location.

• Automated PGx annotation – Users submit PGx test results to PGXI and rapidly query and identify relevant gene-drug associations and conditions linked to specific genotypes.

• Easy, fast, and scalable - Unlike manual or semi-automated approaches to PGx annotation that can take hours or days, PGXI reduces turnaround time to minutes and eliminates the high cost of maintaining bioinformatic and technical support.

Want to try PGXI for free? Learn more about this new knowledgebase and request a free trial here.